Medpace Holdings, Inc. (MEDP) Stock

About Medpace Holdings, Inc.

Medpace Holdings, Inc. is led by CEO August James Troendle, employs 6,200 people, headquartered in Cincinnati, US, publicly traded since 2016.

Medpace Holdings, Inc. (MEDP) stock trades at $602.70 with a market capitalization of $16.82B. The stock is valued at a price-to-earnings (P/E) ratio of 35.86, price-to-book of 40.69, price-to-sales of 6.26. Over the past 52 weeks the stock has ranged between $373.00 and $677.90, and currently trades 11.1% below its 52-week high.

On profitability, Medpace Holdings, Inc. generates a return on equity (ROE) of 110.15% — well above the market average, a sign of a high-quality business, return on capital employed of 93.83%, an operating margin of 21.02%, a net profit margin of 17.67%.

In its most recent fiscal year, Medpace Holdings, Inc. reported annual revenue of $2.5B, net profit of $451.0M, revenue has compounded at 22.3% a year over the last five years, profit at 25.5% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.28 — a conservative balance sheet with little leverage risk, a current ratio of 0.74, total assets of $2.0B, $497.0M in cash and equivalents.

MEDP has a beta of 1.15.